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Bluetongue (BT) is a reportable disease of consider-
able socioeconomic concern and of major importance in 
the international trade of animals and animal products. Be-
fore 1998, BT was considered an exotic disease in Europe. 
From 1998 through 2005, at least 6 BT virus strains belong-
ing to 5 serotypes (BTV-1, BTV-2, BTV-4, BTV-9, and BTV-
16) were continuously present in the Mediterranean Basin. 
Since August 2006, BTV-8 has caused a severe epizootic 
of BT in northern Europe. The widespread recrudescence 
and extension of BTV-8 infections in northern Europe during 
2007 suggest that requirements for BTV establishment may 
now be fulﬁ  lled in this area. In addition, the radial extension 
of BTV-8 across Europe increases the risk for an encounter 
between this serotype and others, particularly those that oc-
cur in the Mediterranean Basin, where vector activity con-
tinues for more of the year. This condition increases the risk 
for reassortment of individual BTV gene segments.
B
luetongue (BT) is an infectious but noncontagious 
viral disease caused by Bluetongue virus (BTV). The 
virus belongs to the family Reoviridae, genus Orbivirus; 
there are 24 serotypes (1). The viral genome consists of 10 
double-stranded RNA segments that encode for 4 nonstruc-
tural proteins (NS1, NS2, NS3, and NS3A) and 7 structural 
(VP1-VP7) proteins (2,3). BTV serotypes 1, 2, 3, 4, 6, and 
10 have a high pathogenic index and high epidemic poten-
tial (4). However, a high genetic diversity of BTV exists 
that is a consequence of both drift (i.e., point mutations) 
and shift (i.e., reassortment of individual BTV gene seg-
ments) so pathogenicity even within a serotype may be 
highly variable (5).
BT is a World Organization for Animal Health report-
able disease and is of considerable socioeconomic concern 
and of major importance in the international trade of ani-
mals and animal products (4). Before 1998, BT was con-
sidered an exotic disease in Europe with just a few sporadic 
incursions (e.g., Spain and Portugal from 1956 through 
1960) (6).
Our aim in this article is to provide a synthesis and 
some perspectives of BT epidemiology in the European 
Union (EU) since BTV’s introduction in 1998. To this ef-
fect, we provide a short overview of the epidemiologic 
situation in Europe, followed by a brief description of the 
susceptible species, a discussion of the vectorial capac-
ity and competence of the Culicoides spp. vectors, and an 
outline of the modes of introduction and mechanisms of 
ampliﬁ  cation.
Epidemiologic Situation in Europe
BTV in EU, 1998–2005
During this 8-year period, at least 6 BTV strains be-
longing to 5 serotypes (BTV-1, BTV-2, BTV-4, BTV-9, 
and BTV-16) have been continuously present in parts of the 
Mediterranean Basin, including several member states of 
the EU (Table, Figure 1) (1,5, 7–12). This emergence of BT 
into parts of Europe never before affected was attributed 
mainly to climate change and was linked to the northern ex-
pansion of the major Old World vector Culicoides imicola 
(Kieffer), which is an Afro-Asiatic species of biting midge 
(13). Additionally, novel indigenous European vector spe-
cies of Culicoides within the Obsoletus and Pulicaris com-
plexes were involved.
In the Mediterranean Basin 2 epidemiologic systems 
seem to predominate. The ﬁ  rst one is located in the east-
ern part of the basin, where serotypes 1, 4, 9, and 16 were 
identiﬁ  ed. In this system, the BTV strains originated in the 
Near, Middle, or Far East. The vectors included other spe-
cies of Culicoides in addition to C. imicola. This ﬁ  nding 
was deduced from the fact that the disease penetrated into 
areas where C. imicola does not occur (the Balkans and 
beyond) (9). The involvement of novel vectors was subse-
quently conﬁ  rmed when the causative virus was isolated 
from mixed pools of 2 species, C. obsoletus (Meigen) and 
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C. scoticus (Downes and Kettle), collected in central Italy 
(14) and from C. pulicaris (Linnaeus) in Sicily (15). The 
second epidemiologic system comprises the western part of 
the Mediterranean Basin, where serotypes BTV-1, BTV-2, 
BTV-4, and BTV-16 were identiﬁ  ed and the main vector 
is C. imicola. Although the appearance of BTV serotype 
16 in this C. imicola system is the result of the westward 
spread of the virus across Europe (16), it is of particular in-
terest because of strong indications that the ﬁ  eld virus may 
represent a reversion to virulence of the attenuated vaccine 
(e.g., in Corsica and in Sardinia in 2004, strains of BTV-16 
isolated from the ﬁ  eld were identical to the live attenuated 
monovalent vaccine strain) (1,11) (Table, Figure 1).
BT in Central and Northern Europe, 
mid-August 2006 to late December 2007
BT was ﬁ  rst identiﬁ  ed in northern Europe in August 
2006 and can be deﬁ  ned as an emergent disease in this zone 
(17). Between the date of the ﬁ  rst report (August 17, 2006) 
and February 1, 2007 (18), 2,122 BT cases were entered 
into the European Commission’s Animal Disease Notiﬁ  ca-
tion System (ADNS) (http://ec.europa.eu/food/animal/dis-
eases/adns/index_en.htm) (Figure 2) (19). In this region, in 
2006, a pool of 50 nonengorged, parous C. dewulﬁ   (Goet-
ghebuer) in the Netherlands were positive by PCR for BTV 
(20), and several pools of C. obsoletus complex in Ger-
many (i.e., not identiﬁ  ed down to species) were also PCR 
positive for BTV (21) (Figure 3). Although isolation of live 
BTV was not attempted in either instance, this research, 
conducted in an area where C. imicola does not occur, con-
ﬁ  rms the earlier ﬁ  ndings of Mellor and Pitzolis, who isolat-
ed infectious BTV from nonengorged parous C. obsoletus 
in Cyprus, and shows that indigenous European Culicoides 
species can support a BT epizootic (22). Because C. obso-
letus complex midges and C. dewulﬁ   occur widely across 
central and northern Europe, this entire area must now be 
considered to be at risk for BTV (23,24).
Moreover, in relation to the demonstrated overwinter-
ing ability of the virus in northern Europe, small numbers 
of adult Culicoides spp. were captured in animal housing 
during the winter period (November 25, 2006, to March 9, 
2007) (i.e., females of C. obsoletus complex, males of C. ob-
soletus, C. scoticus, and C. dewulﬁ  ) (25). Whether the oc-
currence of these midges and the possibility of their activ-
ity extending over the winter in such climatically protected 
locations can explain the persistence of virus from 1 vector 
transmission season to the next (13) or whether they repre-
sent newly emerged midges from nearby breeding sites is 
not known (25). Several hypotheses have been formulated 
to explain the overwintering ability of BTV: by persistence 
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Table. Outbreaks of bluetongue in Europe, 1998–2005*† 
Country  Year of first outbreak  BTV serotype(s)  Main suspected or identified vector(s) 
Albania 2002 9 Culicoides obsoletus, C. pulicaris
Bosnia–Herzegovina 2002 9 ND
Bulgaria 1999 9 C. obsoletus, C. pulicaris
Croatia 2001 9, 16 C. obsoletus, C. scoticus
Cyprus 2003 16 C. imicola, C. obsoletus,
Former Yugoslav Republic of Macedonia  2001 9 ND
France (Corsica)  2000 2, 4, 16‡  C. imicola, C. pulicaris, C. obsoletus
Greece 1998 1, 4, 9, 16  C. imicola, C. obsoletus
Italy  2000 1, 2, 4, 9, 16  C. imicola, C. obsoletus, C. pulicaris
Kosovo 2001 9 ND
Montenegro 2001 9 ND
Portugal 2004 2,§ 4 C. imicola, C. obsoletus, C. pulicaris
Serbia 2001 9 ND
Spain 2000 2 C. imicola,C. obsoletus, C. pulicaris
Turkey  1998 4, 9, 16  C. imicola,C. obsoletus, C. pulicaris
*BTV, Bluetongue virus; ND, no data recorded. 
†Sources: (5,7–10). 
‡This is an insufficiently attenuated vaccine strain (11). 
§This strain is indistinguishable from Onderstepoort BTV-2 live attenuated vaccine strain (7). 
Figure 1. The molecular epidemiology of bluetongue virus (BTV) 
since 1998: routes of introduction of different serotypes and 
individual virus strains. *Presence of BTV-speciﬁ  c  neutralizing 
antibodies in animals in Bulgaria, but the presence of BTV serotype 
8 cannot yet be conﬁ  rmed.Bluetongue Epidemiology in the European Union
within surviving adult vectors themselves, transovarial trans-
mission through the vector, or prolonged/persistent infection 
in viremic or aviremic vertebrate hosts (13,25,26).
The focus of interest now is to see if BTV is able to 
survive regularly between vector seasons and become en-
demic to northern Europe. The recrudescence of BTV-8 in 
northern France, the Netherlands, Belgium, Luxembourg, 
and Germany in 2007, and also the emergence of BTV-8 in 
the United Kingdom, Denmark, Switzerland, and the Czech 
Republic, suggests that this may well be the case (27,28). 
Unlike farther south, where populations of the traditional 
vector, C. imicola, peak in the late summer and autumn, 
when most BT cases occur, populations of the indigenous 
European vectors peak earlier in the year; whether this will 
be reﬂ  ected in a change in the temporal occurrence of BT 
cases remains to be seen. In the period from January 1, 
2006, through December 28, 2007, 12 EU member states 
and Switzerland reported BT outbreaks on their territories, 
comprising all of the serotypes reported in Europe since 1998 
(Figure 4) (29,30).
Susceptible Species
BTV is transmitted between its ruminant hosts almost 
exclusively through the bites of the females of vector species 
of the Culicoides biting midge (31). The global distribution 
of BTV, therefore, is restricted to those regions where these 
vector species of Culicoides occur, and its transmission pe-
riod is limited to the times when adult vectors are active. 
Depending on the species, adult vector activity generally 
starts some time in spring. Activity is positively correlated 
with temperature and reaches a maximum between 28°C 
and 30°C; activity decreases when the temperature drops 
and, for the traditional Afro-Asiatic vector C. imicola, is 
probably nonexistent at temperatures <10°C (13,31).
BTV can infect a broad spectrum of domestic and wild 
ruminants. However, serious clinical signs have been ob-
served only in certain breeds of sheep (improved breeds) 
and a few deer species (32,33). Cattle and goats usually 
exhibit subclinical infections and therefore may serve as 
important and covert viral reservoirs for sheep (32). How-
ever, some serotypes such as serotype 8, which recently 
caused infection in northern Europe, exhibit a more impor-
tant virulence in cattle (34,35) with serious socioeconomic 
consequences (5).
Vector Capacity and Competence
Risk for BTV infection is linked closely to the pres-
ence of adult vector Culicoides spp. (31). Until recently, 
C. imicola was believed to be the only important vector of 
BTV in southern Europe, but it is now known that several, 
newly recognized vector species are also involved. Others 
may be identiﬁ  ed in the future.
Vector competence of an insect species and vector ca-
pacity of an insect population are important parameters in 
this respect (36). Vector competence is the (innate) ability 
of a vector to acquire a pathogen, maintain it, and success-
fully transmit it to a susceptible host (13). Vector compe-
tence may be determined in the laboratory by providing 
groups of insects of a particular species with blood meals 
of appropriate concentrations of virus and assessing infec-
tion and transmission rates. Vector competence is deﬁ  ned 
as the proportion of feeding insects that support virus repli-
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Figure 2. Monthly distribution of conﬁ   rmed bluetongue virus 8 
(BTV-8) outbreaks in northern and central Europe from August 17, 
2006, through February 1, 2007. After January 1, 2007, few BTV 
cases were reported; those that were probably involved animals 
that had been infected, but not detected, in 2006.
Figure 3. A gravid female Culicoides dewulﬁ   collected from a 
location near bluetongue outbreaks in Belgium in 2006 (Photograph: 
Reginald De Deken and Maxime Madder, Institute of Tropical 
Medicine, Antwerp, Belgium).PERSPECTIVE
cation and transmit virus after a suitable incubation period. 
In situations where transmission is difﬁ  cult to demonstrate 
because of the technical problems in refeeding “difﬁ  cult” 
insects such as Culicoides spp., it has become established 
practice to assume transmission if virus can be recovered 
from the salivary glands.
Vector capacity refers to the potential for virus trans-
mission of an insect population and takes into account a 
range of insect, host, and environmental variables, includ-
ing vector abundance, vector survival, biting and transmis-
sion rates, host preferences, and host abundances, under a 
range of external (e.g., bioclimatic) conditions. Vector ca-
pacity can be deﬁ  ned as the number of infective bites that 
an infected vector causes during its lifetime (usually 2–4 
weeks in the case of vector species Culicoides) (36,37).
Determining the 2 parameters explained above is es-
sential to accurately estimate vector transmission rates and 
predict whether BTV will become established in an area. 
Such detailed studies inevitably demand substantial ﬁ  nan-
cial and scientiﬁ  c resources and require a multidisciplinary 
approach.
Modes of Introduction and 
Mechanisms of Ampliﬁ  cation
Introduction of BTV from 1 area into another can occur 
in 4 ways: through animal movement (domestic and wild 
ruminants) or animal product transport (semen, embryos); 
by infected vector Culicoides spp. carried by various liv-
ing (plants, animals) or inanimate (airplanes, ships) means; 
through the active ﬂ  ight of infected vector Culicoides spp. 
(local propagation); and through passive ﬂ  ight of infected 
vector Culicoides spp. on the wind (responsible for long-
distance dissemination).
Whether the virus becomes established in a new area 
depends upon the number and distribution of susceptible 
hosts, the duration and titer of the BTV viremia in the 
hosts, the vector capacity of the local vector population, 
and the ambient temperature. In essence, establishment de-
pends upon a sufﬁ  cient number of vector Culicoides spp. 
becoming infected by feeding upon local viremic hosts, 
surviving long enough to ensure completion of the intrinsic 
incubation period (4–20 days, depending on ambient tem-
perature), and transmitting the virus by bite to new hosts 
(13). The extrinsic incubation period is the interval between 
when a vector is infected and when it ﬁ  rst becomes capable 
of transmitting the BTV to a new host (38). These require-
ments for BTV establishment have clearly been fulﬁ  lled in 
much of southern Europe, as BTV has survived there in 
many locations since the late 1990s.
Conclusions
The widespread recrudescence of BTV-8 infections in 
northern France, Belgium, the Netherlands, Luxembourg, 
and Germany in 2007 and the emergence of BTV-8 in the 
United Kingdom, Denmark, Switzerland, and the Czech 
Republic in the same year suggest that the requirements for 
BTV establishment may now also be fulﬁ  lled in many more 
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Figure 5. Number of bluetongue virus (BTV) outbreaks caused by 
BTV-8 (A) and BTV-1 (B) per kilometer (quartile scale) from May 1, 
2007, to December 28, 2007 (EU-BTNET system; available from 
http://eubtnet.izs.it/btnet).
Figure 4. Number of bluetongue outbreaks in Europe since January 
1, 2006 (all serotypes). BE, Belgium; BG, Bulgaria; CH, Switzerland; 
CS, Czech Republic; DE, Germany; DK, Denmark; ES, Spain; FR, 
France; IT, Italy; LU, Luxembourg; NL, Netherlands; PT, Portugal; 
UK, United Kingdom.Bluetongue Epidemiology in the European Union
northerly and central parts of Europe (in the absence of C. 
imicola). In addition, the radial extension of BTV-8 across 
Europe (including the jump across the English Channel) 
(Figure 5) (39) increases the risk for an encounter between 
this serotype and others, particularly those that occur in the 
Mediterranean Basin (second epidemiologic system). BTV 
serotypes 1, 2, 4, and 16 have been identiﬁ  ed in this area, and 
the addition of a further serotype will considerably increase 
the potential for reassortment between these viruses (Figure 
6) (27,40). Indeed, the number of possible reassortments in 
the case of BTV, which has 10 segments, increases with the 
number of cocirculating serotypes (e.g., 1,024 for 2 sero-
types [210] and 59,049 for 3 serotypes [310]) (4). Moreover, 
the phenomenon of reassortment has already been demon-
strated during the 1998–2005 BTV outbreaks in Europe (5).
Furthermore, in the southern epidemiologic system, C. 
imicola, the Afro-Asiatic vector of BTV, occurs in addition 
to the C. obsoletus complex. As the population abundance 
of C. imicola peaks later in the year than the Obsoletus 
complex, this means that virus may be transmitted for a 
much greater portion of the year.
With regard to prophylaxis, possibly the best strategic 
option for control of clinical BT outbreaks in the European 
endemic areas is vaccination of susceptible animals with 
inactivated vaccines to protect against disease and to ex-
clude the possibility of reversion to virulence of the vaccine 
viruses and reassortment between vaccine and ﬁ  eld strains of 
the virus (4,5). Veterinary authorities and legislators through-
out northern Europe would do well take note of these recent 
and considerable changes in the epidemiology of BT.
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